NeuroGenetics of Alzheimer’s Disease: Crosslinking SIRT1 Gene in the Genetic Nexus of Type II Diabetes and Dementia
Article Sidebar
Main Article Content
Abstract
Background: Background: Type II Diabetes Mellitus (DM) is a chronic condition that not only affects organ function but also contributes to the development of dementia. SIRT1, a gene implicated in the pathophysiology of Type II DM, has been associated with neurodegenerative processes and cognitive decline.
Objective: This study aimed to evaluate the expression of the SIRT1 gene in patients with Type II DM and dementia, elucidating its potential role as a biomarker for cognitive impairment and neurodegeneration in this population.
Methods: A cohort of 88 diabetic patients with dementia and 12 healthy controls were recruited, and EDTA blood samples were collected. SIRT1 serum levels were quantified using chemiluminescent immunoassay (CLIA). Genomic DNA was extracted and assessed for quality before bisulfite DNA modification and Methylation Specific PCR (MSP) to profile SIRT1 gene methylation. Real-time PCR was conducted to determine SIRT1 gene expression levels. Cognitive function was assessed using Mini-Mental State Examination (MMSE) scores.
Results: The average SIRT1 serum levels in diabetic dementia patients (4.98 ± 1.38 µg/mL) were significantly lower than those in healthy controls (14.21 ± 3.64 µg/mL). MMSE scores mirrored this trend, with patients scoring 12.26 ± 4.56, indicating more considerable cognitive impairment compared to healthy controls' score of 24.1 ± 3.12. SIRT1 gene expression was found to be underexpressed with a fold decrease of approximately 4.1 in dementia cases.
Conclusion: The study's findings highlight the downregulated expression of the SIRT1 gene in diabetic patients with dementia, confirming its potential as a biomarker for cognitive decline. Identifying SIRT1 alterations may provide a non-invasive approach for early diagnosis and management of dementia in the diabetic population.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32 Suppl 1:S62-7.
Kerner W, et al. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014;122(7):384-6.
Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer's disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(1):33.
Zhou S, Tang X, Chen HZ. Sirtuins and Insulin Resistance. Front Endocrinol (Lausanne). 2018;9:748.
Kitada M, Ogura Y, Monno I, Koya D. Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function. Front Endocrinol (Lausanne). 2019;10:187.
Gok O, Karaali Z, Ergen A, Ekmekci SS, Abaci N. Serum sirtuin 1 protein as a potential biomarker for type 2 diabetes: Increased expression of sirtuin 1 and the correlation with microRNAs. J Res Med Sci. 2019;24:56.
Zhou B, Li C, Qi W, Zhang Y, Zhang F, Wu JX, Hu YN, Wu DM, Liu Y, Yan TT, Jing Q, Liu MF, Zhai QW. Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Diabetologia. 2012;55(7):2032–2043.
Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E. SIRT1 pathway in Parkinson's disease: a faraway snapshot but so close. Inflammopharmacology. 2023;31(1):37–56.
Lempesis IG, Varrias D, Sagris M, Attaran RR, Altin ES, Bakoyiannis C, Palaiodimos L, Dalamaga M, Kokkinidis DG. Obesity and Peripheral Artery Disease: Current Evidence and Controversies. Curr Obes Rep. 2023;12(3):264–279.
Stewart MD, Li J, Wong J. Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol Cell Biol. 2005;25(7):2525–2538.
Razick DI, Akhtar M, Wen J, Alam M, Dean N, Karabala M, Ansari U, Ansari Z, Tabaie E, Siddiqui S. The Role of Sirtuin 1 (SIRT1) in Neurodegeneration. Cureus. 2023;15(6):e40463.
Kueper JK, Speechley M, Montero-Odasso M. The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review. J Alzheimers Dis. 2018;63(2):423–444.
Mehramiz M, Porter T, Laws SM, Rainey-Smith SR. Sleep, Sirtuin 1 and Alzheimer's disease: A review. Aging Brain. 2022;2:100050.
Yang H, Cheng Z, Li Z, Jiang Y, Zhao J, Wu Y, Gu S, Xu H. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities. Int J Geriatr Psychiatry. 2019;34(11):1658–1666.
Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88(11):1322–1335.
Zhang HH, Ma XJ, Wu LN, Zhao YY, Zhang PY, Zhang YH, Shao MW, Liu F, Li F, Qin GJ. SIRT1 attenuates high glucose-induced insulin resistance via reducing mitochondrial dysfunction in skeletal muscle cells. Exp Biol Med (Maywood). 2015;240(5):557–565.
Spinelli M, Fusco S, Grassi C. Brain Insulin Resistance and Hippocampal Plasticity: Mechanisms and Biomarkers of Cognitive Decline. Front Neurosci. 2019;13:788.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016;11:95–104.
Rajmohan R, Reddy PH. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons. J Alzheimers Dis. 2017;57(4):975–999.
Mehramiz M, Porter T, O'Brien EK, Rainey-Smith SR, Laws SM. A Potential Role for Sirtuin-1 in Alzheimer's Disease: Reviewing the Biological and Environmental Evidence. J Alzheimers Dis Rep. 2023;7(1):823–843.
Fernando KKM, Wijayasinghe YS. Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer's Disease. Front Cell Neurosci. 2021;15:746631.
Hadar A, Milanesi E, Walczak M, Puzianowska-Kuźnicka M, Kuźnicki J, Squassina A, Niola P, Chillotti C, Attems J, Gozes I, Gurwitz D. SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease. Sci Rep. 2018;8(1):8465.
Ng F, Wijaya L, Tang BL. SIRT1 in the brain-connections with aging-associated disorders and lifespan. Front Cell Neurosci. 2015;9:64.
Yin Q, Shen L, Qi Y, Song D, Ye L, Peng Y, Wang Y, Jin Z, Ning G, Wang W, Lin D, Wang S. Decreased SIRT1 expression in the peripheral blood of patients with Graves' disease. J Endocrinol. 2020;246(2):161–173.